Adaptive Biotechnologies President and COO Julie Rubinstein Reports Sale of $998,097.44 in Common Shares

PUBT · 2d ago
Adaptive Biotechnologies President and COO Julie Rubinstein Reports Sale of $998,097.44 in Common Shares
  • Adaptive Biotechnologies President and COO Julie Rubinstein sold 35,643 common shares Oct. 27-29, 2026, according to a Form 4.
  • Rubinstein exercised stock options for the same number of shares at $12.14 per share during the period.
  • Her direct holdings remained at 377,802 common shares, with 130,276 stock options remaining following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adaptive Biotechnologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001780664-26-000047), on October 29, 2026, and is solely responsible for the information contained therein.